Thus we now show for the first time a direct link between a Bcl-2 family member and a specific NADPH oxidase and illustrate that Mcl-1 has a unique ability to inhibit ROS production by preventing the up regulation of the pro-oxidant NOX4, ultimately leading to CIS resistance. This evidence concerns the gene BCL2 and in situ carcinoma.